Randomised controlled trials, controlled clinical trials and prospective cohort studies with specified follow-up of home monitoring of infants under two years of age and that evaluated mortality data were eligible for inclusion.
The included population were healthy full-term infants with family history of SIDS or siblings of deceased infants whose death were attributed to SIDS, and at-risk infants including those with sleep apnoea, premature infants, infants of mothers with substance-use disorders and infants with previous apparent life threatening events. The monitors included were cardiorespiratory monitors, including heart rate monitors, apnoea monitors and movement detection monitors.
Two reviewers independently performed the study selection.